The drugs known as antibiotics are used to treat bacterial infections. Antibiotics are sometimes used to treat parasitic infections as well. These medicines aid in the treatment of bacterial infections in both humans and animals. Antibiotics help destroy or slow the growth of bacteria by either killing them or stopping them from reproducing. They are useless against viral infections like the flu or the common cold. Infections can be treated with antibiotics, which have also saved countless lives. They may, however, have negative side effects and increase antibiotic resistance.
By the end of 2022, the global antibiotics market is anticipated to generate US$ 51,378.2 Mn in revenue.
Over the forecast period, the global antibiotics market is anticipated to grow at a high rate due to the increased prevalence of infectious diseases around the world. For instance, the U.S. Food and Drug Administration (FDA) approved the antibiotic Recarbrio in June 2020 to treat ventilator-associated bacterial pneumonia (VABP) and hospital-acquired bacterial pneumonia (HABP). Recarbrio was previously FDA-approved to treat complicated intra-abdominal infections and urinary tract infections in patients with few or no other treatment options.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/5325
The world’s ageing population is predicted to create sizable growth opportunities for companies in the antibiotics industry. For instance, the burden of infectious diseases is rising along with the ageing population. The consumption of antibiotics as a result is rising (has been rising) globally. The World Health Organization (WHO) predicts that by 2030, 1 in 6 people worldwide will be 60 years of age or older, and that number will have doubled by 2050. (2.1 billion).
Major factors that are anticipated to impede the growth of the global antibiotics market include the high cost of trials and research, an increase in the prevalence of antibiotic resistance, and a lengthier timeframe for regulatory approval. As an illustration, antibiotic resistance is a significant public health issue. Poor infection prevention and control, as well as the improper and excessive use of antibiotics, all contribute to its acceleration. One of the biggest threats to the general public’s health is this one. Additionally, the World Health Organization (WHO) listed 10 urgent threats for 2019 and antibiotic resistance was one of them.
The COVID-19 outbreak has had two effects on the expansion of the world antibiotics market. Due to safety precautions taken to stop the virus’s spread, such as a national lockdown and travel restrictions, the pandemic had an effect on the world’s pharmaceutical supply chain. Antibiotics, however, were in greater demand because they were initially prescribed and researched as a COVID-19 treatment because they were used to treat COVID-19.
The global antibiotics market was estimated to be worth US$ 49,081.2 Mn in 2021 and is anticipated to grow at a CAGR of 4.7% between 2022 and 2028 to reach US$ 67,874.0 Mn.
Cephalosporin held a dominant position in the product type segment of the global antibiotics market in 2021, accounting for 24.2% share in terms of value. Increasing approval and the introduction of new products is anticipated to fuel segment growth during the forecast period.
Due to an increase in the prevalence of infectious diseases around the world, there has been a recent trend in the global antibiotics market toward increased demand for newer generations of antibiotics and increased development of safe and effective antibiotics. Worldwide demand for new generation antibiotics has increased as a result of the increased public concern about antibiotic resistance. As a result, market participants are concentrating on creating and releasing safer/more effective newer generations of antibiotics, and this trend is anticipated to persist during the forecast period, fueling the market’s expansion.
Bayer Healthcare AG, Roche Holding AG, GlaxoSmithKline, Johnson & Johnson, Abbott Laboratories, Merck & Co. Inc., Sanofi SA, Pfizer Inc., Novartis AG, and AstraZeneca are a few of the major companies that compete in the global antibiotics market.
Otsuka received authorization for a further paediatric indication in Europe in October 2021. In support of that endeavour, Otsuka has been working to increase DELTYBA’s accessibility throughout the world.
To find, create, and market novel antibiotic classes, Forge Therapeutics, Inc. (Forge) and Basilea Pharmaceutica International Ltd. (Basilea) entered into a research collaboration and licence agreement in April 2019.
We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/5325
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Antibiotics Market Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Antibiotics Market Industry Impact
Chapter 2 Global Antibiotics Market Competition by Types, Applications, and Top Regions and Countries
2.1 Global Antibiotics Market (Volume and Value) by Type
2.3 Global Antibiotics Market (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Antibiotics Market Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Antibiotics Market Market Analysis
Chapter 6 East Asia Antibiotics Market Market Analysis
Chapter 7 Europe Antibiotics Market Market Analysis
Chapter 8 South Asia Antibiotics Market Market Analysis
Chapter 9 Southeast Asia Antibiotics Market Market Analysis
Chapter 10 Middle East Antibiotics Market Market Analysis
Chapter 11 Africa Antibiotics Market Market Analysis
Chapter 12 Oceania Antibiotics Market Market Analysis
Chapter 13 South America Antibiotics Market Market Analysis
Chapter 14 Company Profiles and Key Figures in Antibiotics Market Business
Chapter 15 Global Antibiotics Market Market Forecast (2022-2028)
Chapter 16 Conclusions
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/5325
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States
Phone: US +12067016702 / UK +4402081334027